Novartis financial data

Novartis financial data

Novartis provides the following information on the Group's strong financial performance since its creation in 1996.

Annual results

Novartis annual results conference, including media releases and year-to-date figures.

Quarterly results

View recent and archived quarterly results.

SEC filings

Use the SEC’s EDGAR system to search and review all US disclosure filings by Novartis.

Fixed-income securities

Learn about the fixed-income securities issued by Novartis.

Product sales

View net sales data of the top 20 brands in 2024.

Expected currency impact

Expected currency impact, if mid-March exchange rates prevail in 2025.
Kate Kostelyk, IgA nephropathy (IgAN) patient, and her labrador Dakoda in Mims, Florida

Reporting and transparency hub

Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.

Learn more
Source URL: https://prod1.novartis.com/investors/financial-data

List of links present in page
  1. https://prod1.novartis.com/investors/financial-data
  2. https://prod1.novartis.com/investors/financial-data/annual-results
  3. https://prod1.novartis.com/investors/financial-data/quarterly-results
  4. https://prod1.novartis.com/investors/financial-data/sec-filings
  5. https://prod1.novartis.com/investors/financial-data/fixed-income-securities
  6. https://prod1.novartis.com/investors/financial-data/product-sales
  7. https://prod1.novartis.com/investors/financial-data/expected-currency-impact
  8. https://prod1.novartis.com/investors/reporting-and-transparency-hub